10.21147/j.issn.1000-9604.2016.04.08
A phase Ⅰ trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
deacetylase inhibitor
28
R3
This study was supported in part by grants from Chinese National Major Project for New Drug Innovation 2012ZX09303012-001
2016-09-29(万方平台首次上网日期,不代表论文的发表时间)
共8页
444-451